Avoro Capital Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,275,000
| Closed | -$30.1M | – | 40 |
|
|
2024
Q4 | $30.1M | Sell |
2,275,000
-1,613,437
| -41% | -$21.3M | 0.43% | 31 |
|
|
2024
Q3 | $74.9M | Hold |
3,888,437
| – | – | 1.09% | 20 |
|
|
2024
Q2 | $79.8M | Sell |
3,888,437
-333,785
| -8% | -$6.85M | 1.06% | 23 |
|
|
2024
Q1 | $100M | Hold |
4,222,222
| – | – | 1.17% | 22 |
|
|
2023
Q4 | $91.2M | Buy |
4,222,222
+1,666,667
| +65% | +$36M | 1.26% | 20 |
|
|
2023
Q3 | $37.1M | Sell |
2,555,555
-94,445
| -4% | -$1.37M | 0.58% | 24 |
|
|
2023
Q2 | $55.5M | Hold |
2,650,000
| – | – | 0.75% | 23 |
|
|
2023
Q1 | $56M | Hold |
2,650,000
| – | – | 0.83% | 20 |
|
|
2022
Q4 | $67.4M | Buy |
2,650,000
+427,778
| +19% | +$10.9M | 1.01% | 19 |
|
|
2022
Q3 | $53.4M | Hold |
2,222,222
| – | – | 0.99% | 18 |
|
|
2022
Q2 | $42.8M | Buy |
2,222,222
+1,722
| +0.1% | +$33.1K | 0.84% | 22 |
|
|
2022
Q1 | $38.6M | Buy |
2,220,500
+45,500
| +2% | +$791K | 0.7% | 22 |
|
|
2021
Q4 | $47.6M | Buy |
2,175,000
+630,000
| +41% | +$13.8M | 0.81% | 20 |
|
|
2021
Q3 | $29.5M | Sell |
1,545,000
-1,455,000
| -49% | -$27.8M | 0.46% | 31 |
|
|
2021
Q2 | $51.5M | Buy |
3,000,000
+500,000
| +20% | +$8.59M | 0.9% | 25 |
|
|
2021
Q1 | $55.9M | Buy |
2,500,000
+2,050,000
| +456% | +$45.8M | 0.97% | 22 |
|
|
2020
Q4 | $10M | Buy |
+450,000
| New | +$10M | 0.17% | 40 |
|